Platelet glycoprotein IIb/IIIa inhibition in acute coronary syndromes. Gradient of benefit related to the revascularization strategy
about
Early invasive versus conservative strategies for unstable angina and non-ST elevation myocardial infarction in the stent eraRoutine invasive strategies versus selective invasive strategies for unstable angina and non-ST elevation myocardial infarction in the stent eraGlycoprotein IIb/IIIa inhibitors use and outcome after percutaneous coronary intervention for non-ST elevation myocardial infarction.Therapeutic strategies, immediate and mid-term outcomes in non-ST-segment elevation acute coronary syndromes with respect to age: a single-center registry of 488 consecutive patients.Current strategies with high-dose tirofiban.Present and evolving role of eptifibatide in the treatment of acute coronary syndromes.Glycoprotein IIb/IIIa receptor inhibitors in 2008: do they still have a role?Antithrombotic therapy in patients with diabetes mellitus and coronary artery disease.Current concepts on coronary revascularization in diabetic patients.Optimal use of platelet glycoprotein IIb/IIIa receptor antagonists in patients undergoing percutaneous coronary interventions.Management of acute coronary syndrome: achievements and goals still to pursue. Novel developments in diagnosis and treatment.Update on platelet glycoprotein IIb/IIIa inhibitors: recommendations for clinical practice.Progress in the research of GPIIb/IIIa antagonists.Investigational new drugs for the treatment of acute coronary syndrome.Clinical pathways and management of antithrombotic therapy in patients with acute coronary syndrome (ACS): a Consensus Document from the Italian Association of Hospital Cardiologists (ANMCO), Italian Society of Cardiology (SIC), Italian Society of EThe progress in the research of antiplatelet agents (1995-2017).Safety and efficacy of IIb/IIIa inhibitors in combination with highly active oral antiplatelet regimens in acute coronary syndromes: A meta-analysis of pivotal trials.Comparison of prasugrel and clopidogrel-treated patients with acute coronary syndrome undergoing percutaneous coronary intervention: A propensity score-matched analysis of the Acute Myocardial Infarction in Switzerland (AMIS)-Plus Registry.Current guidance on the management of acute coronary syndrome.Antithrombotic therapy in medically managed patients with non-ST-segment elevation acute coronary syndromes.Monitoring persistent platelet reactivity in patients with unprotected left main stenting.Antithrombotic Therapy for ACS in Elderly Patients.
P2860
Q24236794-0E65758B-2C43-4C75-B550-BC5AFDE48DC0Q26471900-2848B347-650E-4AC0-BDE7-D2A90EF37A81Q33666662-1D58BD6D-9EC5-42EA-B997-159B08DA4E3EQ35878091-01E14A2E-C256-4641-9956-A01AD2334FCDQ36788433-5921F1B7-C9B8-4E6F-9449-6BADEBA0B5DDQ36815950-D243C58D-27CE-48F6-8D08-870D880C477BQ37126729-4D1F4427-51E1-452A-9F65-C7B602622D23Q37797795-E09C5A6F-CC44-423E-99AF-CADF26E05FAEQ37926750-A258DFEF-BB8C-41C2-8A96-4F2AD8A7F887Q37943829-01117CB2-C720-4188-92E5-B9A26C898B0BQ37984773-9EDD4F1C-380D-4C63-A54B-1FE40B7C6DB3Q38118745-981F289D-962B-4002-917D-B5D776207A0AQ38541493-6485FB9B-4C4E-4D6F-BE0D-58FC9853E2CFQ38594609-15C371C6-1EB4-4A86-A45C-0624C686EDD9Q38656364-D2499816-3EBA-4E94-A7B8-3C7AC7CACF52Q38669003-60D15192-4E82-49CB-A25D-006FED5BE623Q38961670-CBEE93C3-0F4A-4776-980C-0DDAF454C77FQ41538436-CA5192A9-2C95-4A65-8BD1-A3D9DD82E28CQ43191606-97DB2D59-EEAB-44E9-97A1-1A26B909E8A4Q45028902-51F5C8AE-B50B-46E2-86D7-63DFF35A3944Q46171896-4F9EA6C2-50EA-4C27-9DB0-F0A10EEB179FQ47632915-4C9FFEB9-3A04-4A10-AF80-A46942624051
P2860
Platelet glycoprotein IIb/IIIa inhibition in acute coronary syndromes. Gradient of benefit related to the revascularization strategy
description
im September 2002 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 September 2002
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована у вересні 2002
@uk
name
Platelet glycoprotein IIb/IIIa ...... the revascularization strategy
@en
Platelet glycoprotein IIb/IIIa ...... the revascularization strategy
@nl
type
label
Platelet glycoprotein IIb/IIIa ...... the revascularization strategy
@en
Platelet glycoprotein IIb/IIIa ...... the revascularization strategy
@nl
prefLabel
Platelet glycoprotein IIb/IIIa ...... the revascularization strategy
@en
Platelet glycoprotein IIb/IIIa ...... the revascularization strategy
@nl
P2093
P356
P1476
Platelet glycoprotein IIb/IIIa ...... the revascularization strategy
@en
P2093
C Heeschen
D J Moliterno
M A Robbins
N S Kleiman
P304
P356
10.1053/EUHJ.2002.3160
P577
2002-09-01T00:00:00Z